In Reply We thank Abdollah et al, Berg et al, and Chandrasekar et al for their feedback regarding our article.1
First, we apologize for the inadvertent swap of the prostate-specific antigen (PSA) ranges for the adjuvant radiotherapy (ART) and early-salvage radiotherapy (ESRT) groups introduced during the final stages of the journal’s copyediting process. This was corrected in the online and print abstracts.2